Glory Health Industry Limited reported that its share capital structure remained unchanged for the month ended 31 May 2026.

Key data highlights:

• Authorised share capital stood at 10.00 billion ordinary shares with a par value of HKD 0.001 each, representing HKD 10.00 million in authorised capital; no increase or decrease was recorded during the month.

• Issued share capital totalled 4.44 billion ordinary shares, identical to the prior month’s balance. The company held no treasury shares.

• Public-float requirements under Main Board Rule 13.32D(1) were met, with at least 15% of issued shares held by the public as mandated at the time of listing.

• The issuer reported no activity in share options, warrants, convertible instruments, or other equity-related agreements, and no additional share movements or Hong Kong Depositary Receipts during the period.

The submission, dated 3 June 2026 and signed by Chairman Zhang Zhangsun, confirms compliance with all applicable listing rules and regulatory obligations.